adicet bio logo.png
Adicet Bio to Present at the Cantor Virtual Global Healthcare Conference
September 15, 2020 16:10 ET | Adicet Bio, Inc.
MENLO PARK, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq:  ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and...
Adicet Announces Completion of Merger with resTORbio
September 15, 2020 08:55 ET | resTORbio, Inc.
- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology - -Trading to Commence on September 16, 2020 on The Nasdaq Global Market Under Ticker Symbol “ACET”- ...
PDF to PNG Logo.png
DCOM, TORC, GRUB, and NGHC SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
July 13, 2020 15:36 ET | Rigrodsky & Long, P.A.
WILMINGTON, Del., July 13, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Dime Community Bancshares, Inc. (NASDAQ GS: DCOM) regarding possible breaches of...